Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease

FASEB Journal

Volumn 14, Issue 10, 2000, Pages 1432-1438

  Di Marzo, Vincenzo ^b   Hill, Michael P ^c   Bisogno, Tiziana ^b   Crossman, Alan R ^a   Brotchie, Jonathan M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CNR   (Italy)

^c Williams House   (United Kingdom)

Author keywords

2 arachidonoyl glycerol; Anandamide; Cannabinoids; Dopamine; Receptors

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; BENZAZEPINE DERIVATIVE; CANNABINOID; DOPAMINE RECEPTOR STIMULATING AGENT; QUINPIROLE; RESERPINE; RIMONABANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BODY MOVEMENT; BRAIN LEVEL; BRAIN REGION; CONTROLLED STUDY; GLOBUS PALLIDUS; LOCOMOTION; MALE; MOTOR CONTROL; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALIA; TRIXIS;

EID: 0033936028     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.14.10.1432     Document Type: Article

References (15)

1. Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., and Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949
2. Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almong, S., Martin, B. R., Compton, D. R., et al. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50, 83-90
3. Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., and Waku, K. (1995) 2-Arachidonoyl-glycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215, 89-97
4. Di Marzo, V., Melck, D., Bisogno, T., and De Petrocellis, L. (1998) Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci. 21, 521-528
5. Herkenham, M., Lynn, A. B., de Costa, B. R., and Richfield, E. K. (1991) Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res. 547, 267-274
6. Glass, M., Brotchie, J. M., and Maneuf, Y. P. (1997) Modulation of neurotransmission by cannabinoids in the basal ganglia. Eur. J. Neurosci. 9, 199-203
7. Romero, J., Garcia, L., Cebeira, M., Zadrozny, D., Fernandez-Ruiz, J. J., Ramos, J. A. (1995) The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons. Life Sci. 56, 2033-2040
8. Pertwee, R. G. (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther. 74, 129-180
9. Penney, J. B., and Young, A. B. (1986) Striatal inhomogeneities and basal ganglia function. Movement Dis. 1, 3-15
10. Smith, Y., Bevan, M. D., Shink, E., and Bolam, J. P. (1998) Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience 86, 353-387
11. Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., Jr., and Sibley, D. R. ( 1990) Dl and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250, 1429-1432
12. Maneuf, Y. P., Crossman, A. R., and Brotchie, J. M. (1996) Modulation of GABAergic transmission in the globus pallidus by the synthetic cannabinoid WIN 55,212-2. Synapse 22, 382-385
13. Maneuf, Y. P., Nash, J. E., Crossman, A. R., and Brotchie, J. M. (1996) Activation of the cannabinoid receptor by delta 9-tetra-hydrocannabinol reduces γ-aminobutyric acid uptake in the globus pallidus. Eur. J. Pharmacol. 308, 161-164
14. Pertwee, R. G., and Wickens, A. P. (1991) Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids. Neuro-pharmacology 30, 237-244
15. Maneuf, Y. P., Crossman, A. R., and Brotchie, J. M. (1997) The cannabinoid receptor agonist WIN 55,212-2 reduces D2, but not Dl, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson's disease. Exp. Neurol. 148, 265-270